Conatus Jumps on Orphan Drug Status

Published December 11, 2013

Conatus jumps on orphan drug status
[rewrite]Shares of Conatus Pharmaceuticals jumped 18 percent Tuesday after the San Diego biotech company said it got orphan drug designation for emricasan, its experimental liver drug. Conatus is testing emricasan for chronic liver diseases and complications.[/rewrite]
Read more on U-T San Diego

Life Tech Becomes Partner in Saudi Human Genome Program, International …
[rewrite]In his new role, deSouza will report to CEO Jay Flatley and will lead the San Diego company's business units. He will also join Illumina's executive management team. DeSouza will join Illumina in December. He currently serves as president of products …[/rewrite]
Read more on GenomeWeb

Drug Rehab Centers in San Diego | Rehab in San Diego | Drug Rehab Centers in San Diego — http://www.rehabsandiego.net/ Drug Rehab Centers in San Diego help you get you life back. San Diego Rehab Center help people in getting detox in San Diego, r…

Related Drug Treatment Programs In San Diego Information…